MITBX
Price
$35.93
Change
+$0.12 (+0.34%)
Updated
Aug 21 closing price
Net Assets
6.97B
VFFSX
Price
$376.01
Change
+$1.65 (+0.44%)
Updated
Aug 21 closing price
Net Assets
1.69T
Interact to see
Advertisement

MITBX vs VFFSX

MITBX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
MITBX vs. VFFSX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MITBX is a StrongBuy and VFFSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.69T vs. MITBX (6.97B). VFFSX pays higher dividends than MITBX: VFFSX (1.08) vs MITBX (0.00). MITBX was incepted earlier than VFFSX: MITBX (33 years) vs VFFSX (10 years). MITBX (1.44) is less costly to investors than VFFSX (0.01). MITBX is a more actively managed with annual turnover of: 26.00 vs. VFFSX (2.00). MITBX has a lower initial minimum investment than VFFSX: MITBX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 20.51 vs. MITBX (1.53). VFFSX return over 5 years is better than : 73.03 vs. MITBX (-12.79).
MITBXVFFSXMITBX / VFFSX
Total Expense Ratio1.440.0114,400%
Annual Report Gross Expense Ratio1.440.0114,400%
Fund Existence33 years10 years-
Gain YTD9.04412.25874%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.97B1.69T0%
Annual Yield % from dividends0.001.08-
Returns for 1 year1.5320.517%
Returns for 3 years8.6475.1612%
Returns for 5 years-12.7973.03-18%
Returns for 10 years28.18251.2611%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCEX105.501.05
+1.01%
Rydex Europe 1.25x Strategy C
LVAVX17.340.12
+0.70%
LSV Conservative Value Equity Investor
NWAEX20.360.08
+0.39%
Nationwide BNY Mellon Dyn US Core Eagle
WWIAX13.510.03
+0.22%
Westwood Income Opportunity A
JFNSX87.14N/A
N/A
Janus Henderson Global Life Sciences S